Bicycle Therapeutics PLC
BCYC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761612
No open-market purchases or sales by Bicycle Therapeutics PLC insiders were filed in the last 90 days; 103 institutions reported holding it in 13F filings for Q2 2026, worth $157.9M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Bicycle Therapeutics PLC changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 95 | 110 | +15 |
| Shares | 41.7M | 41.2M | −534.9K (−1.3%) |
| Value | $354.4M | $286.3M | −$68.0M (−19.2%) |
New holders (29)
Institutions that held Bicycle Therapeutics PLC at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (14)
Institutions that held Bicycle Therapeutics PLC at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Ra Capital Management, L.P. | 1,093,477 | $9.28M |
| EcoR1 Capital, LLC | 910,000 | $7.73M |
| Aquilo Capital Management, LLC | 171,695 | $1.46M |
| Caption Management, LLC | 81,559 | $692.4K |
| Shay Capital LLC | 60,000 | $509.4K |
| EntryPoint Capital, LLC | 28,857 | $245.0K |
| Exchange Traded Concepts, LLC | 12,764 | $108.4K |
| Envestnet Asset Management Inc | 12,420 | $105.4K |
| Gsa Capital Partners LLP | 11,952 | $101.0K |
| Deutsche Bank AG | 6,417 | $54.5K |
| Boston Private Wealth LLC | 210 | $1.78K |
| Bell Investment Advisors, Inc | 22 | $187 |
| EverSource Wealth Advisors, LLC | 13 | $110 |
| Steward Partners Investment Advisory, LLC | 10 | $85 |